Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma

Cancer Letters

Volumn 193, Issue 1, 2003, Pages 109-114

  Jaboin, Jerry ^a   Hong, Audrey ^a   Kim, Chong Jai ^b   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Brain derived neurotrophic factor; Cisplatin; Neuroblastoma; Phosphatidylinositol 3 kinase; TrkB

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CISPLATIN; K 252A; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL STIMULATION; CELL SURVIVAL; CHEMOSENSITIVITY; CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0037430992     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00723-1     Document Type: Article

References (25)

1. Brodeur G., Pritchard J., Berthold F., Carlsen N., Castel V. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol. 11:1993;1466-1477.
2. Nakagawara A., Arima-Nakagawara M., Scavarda N., Azar C., Cantor A., Brodeur G. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328:1993;847-854.
3. Brodeur G.M., Nakagawara A., Yamashiro D.J., Ikegaki N., Liu X.-G., Azar C.G., Lee C.P., Evans A.E. Expression of trkA, trkB, and trkC in human neuroblastoma. J. Neuro. Oncol. 31:1997;49-55.
4. Matsumoto K., Wada R.K., Yamashiro J.M., Kaplan D.R., Thiele C.J. Expression of brain-derived neurotrophic factor and p145trkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res. 55:1995;1798-1806.
5. Feng X., Jiang H., Baik J.C., Edgar C., Eide F.F. BDNF dependence in Neuroblastoma. J. Neurosci. Res. 64:2001;355-363.
6. Kaplan D.R., Matsumoto K., Lucarelli E., Thiele C.J. Induction of trkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron. 11:1993;321-331.
7. Nakagawara A., Azar C., Scavarda N., Brodeur G. Expression and function of TRK-B and BDNF in human neuroblastoma. Mol. Cell Biol. 14:1994;759-767.
8. Scala S., Wosikowski K., Giannakakou P., Valle P., Biedler J.L., Spengler B.A., Lucarelli E., Bates S.E., Thiele C.J. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res. 56:1996;3737-3742.
9. Middlemas D.S., Kihl B.K., Zhou J., Zhu X. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J. Biol. Chem. 274:1999;16451-16460.
10. Jaboin J., Kim C.J., Kaplan D.R., Thiele C.J. BDNF activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via PI-3 kinase. Cancer Res. 62:2002;6756-6763.
11. Ventimiglia R., Mather P., Jones B., Lindsay R. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7:1995;213-222.
12. Acheson A., Conover J., Fandl J., DeChiara T., Russel M., Thadani A., Squinto S., Yancopoulos G., Lindsay R. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 30:1995;405-406.
13. Alcantara S., Frisen J., del Rio J.A., Soriano E., Barbacid M., Silos-Santiago I. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J. Neurosci. 17:1997;3623-3633.
14. Cheng B., Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640:1994;56-67.
15. Lindholm D., Dechant G., Heinsenberg C., Thoenen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci. 5:1993;1455-1464.
16. Shimohama S., Tamura Y., Akaike A., Tsukahara T., Ohara O., Watanabe S., Kimura J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neuroscience. 164:1993;55-58.
17. Courtney M.J., Akerman K.E., Coffey E.T. Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism. J. Neurosci. 17:1997;4201-4211.
18. Kim C.J., Matsuo T., Lee K.H., Thiele C.J. Up-regulation of insulin growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Am. J. Pathol. 155:1999;1661-1670.
19. Lindvall O., Kokaia Z., Bengzon J., Elmer E., Kokaia M. Neurotrophins and brain insults. Trends Neurosci. 17:1994;490-496.
20. Cortazzo M.H., Kassis E.S., Sproul K.A., Schor N.F. Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor. J. Neurosci. 16:1996;3895-3899.
21. Miller F.D., Kaplan D.R. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol. Life Sci. 58:2001;1045-1053.
22. Han B.H., Holtzman D.M. BDNF protects the neonatal brain from hypozix-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20:2000;5775-5781.
23. Skaper S.D., Floreani M., Negro A., Facci L. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J. Neurochem. 70:1998;1859-1868.
24. Klocker N., Kermer P., Weishaupt J.H., Labes M., Ankerhold R., Bahr M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3′-kinase/protein kinase B signaling. J. Neurosci. 20:2000;6962-6967.
25. Evans A.E., Kisselbach K.D., Liu X., Eggert A., Ikegaki N., Camoratto A.M., Dionne C., Brodeur G.M. Effect on CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB. Med. Pediatr. Oncol. 36:2001;181-184.